Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Chronicle Bio Appoints Dr. John Mumm As Chief Scientific Officer

PRIVATEJun 11, 20266 days ago

Position

Chief Scientific Officer

Company

ChronicleBio

John Mumm
San FranciscoBiotechnologyHealth CareArtificial Intelligence

Description

ChronicleBio has announced the appointment of Dr. John Mumm as Chief Scientific Officer. Mumm, a seasoned immunology innovator, brings extensive expertise to the company as it aims to address neuroimmune conditions.

Company Information

Company

ChronicleBio

Location

San Francisco, California, United States

About

ChronicleBio is a data-driven techbio company utilizing advances in multi-omics and artificial intelligence. The company is focused on transforming drug development for neuroimmune conditions that have traditionally been viewed as incurable. Their mission is to change how chronic diseases are understood and treated, aiming to improve outcomes for millions of patients. ChronicleBio combines innovative biological research with cutting-edge technology to offer tailored therapeutic solutions.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for ChronicleBio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.